SP-MHCI-0662-3

Human Insulin 39-47, LYLVCGERG

US$507.00

In stock

Description

About Human Insulin 39-47, LYLVCGERG

The Human Insulin Peptide (IEDB: 102639) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Insulin Peptide, H-LYLVCGERG-OH (Uniprot: P01308 aa: 39-47) from JPT is produced under strict quality control and quality management.

Human Insulin 39-47, LYLVCGERG - Specifications

  • Peptide sequence: H-LYLVCGERG-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Diabetes, Prediabetes
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Insulin 39-47, LYLVCGERG

References:
Read References with JPT’s Antigen Peptides
Human Insulin 39-47, LYLVCGERG has been described in:
Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice., J Immunol, 2008 (PMID: 18390725)
Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus., Proc Natl Acad Sci U S A, 2002 (PMID: 11943852)
Development of a T-cell receptor multimer with high avidity for detecting a naturally presented tumor-associated antigen on osteosarcoma cells., Cancer Sci, 2019 (PMID: 30375705)

Documentation

Documentation for Human Insulin 39-47, LYLVCGERG

Properties

Properties of Human Insulin 39-47, LYLVCGERG

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Diabetes, Prediabetes
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Insulin
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Insulin 39-47, LYLVCGERG

Information Values
Sequence: H-LYLVCGERG-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote